 |
| Kate Coyle |
ICR Inc. has recruited Weber Shandwick alum, Kate Coyle, as senior VP in its healthcare practice.
Most recently executive VP at the Interpublic unit, Coyle has experience in leading large-scale disease awareness programs, as well as corporate, product and franchise initiatives covering every stage of the pharma and biotech product life cycle.
Prior to Weber, she was group director at both W2O Group and Makovsky & Co.
Coyle joins ICR's Westwicke unit, which it acquired in January. Based in Baltimore and recast as Westwicke, an ICR Company is a health-centered investor relations firm with offices in New York, Boston, San Diego, San Francisco and London.
ICR also added Doug Donsky as managing director in New York.
He joins from FTI Consulting, where he was senior managing director in the strategic communications unit in charge of a team of more than 40 corporate and financial staffers.
ICR trails only Edelman in O'Dwyer's rankings of financial PR firms.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
